Therapeutic insights into the treatment of Parkinson’s disease: Acarbose, an anti-diabetic drug used to treat non-insulin-dependent Diabetes Mellitus, suppessses the expression of Parkinson’s disease-related leucine-rich repeat kinase 2 (LRRK2) protein via up regulation of its target gene, 14/March/2014, 22.25

Therapeutic insights into the treatment of Parkinson’s disease: Acarbose, an anti-diabetic drug used to treat non-insulin-dependent Diabetes Mellitus, suppessses the expression of Parkinson’s disease-related leucine-rich repeat kinase 2 (LRRK2) protein via up regulation of its target gene, 14/March/2014, 22.25

Therapeutic insights into the treatment of Parkinson’s disease: Acarbose, an anti-diabetic drug used to treat non-insulin-dependent Diabetes Mellitus, suppessses the expression of Parkinson’s disease-related leucine-rich repeat kinase 2 (LRRK2) protein via up regulation of its target gene, 14/March/2014, 22.25 150 150

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Therapeutic insights into the treatment of Parkinson’s disease: Acarbose, an anti-diabetic drug used to treat non-insulin-dependent Diabetes Mellitus, suppessses the expression of Parkinson’s disease-related leucine-rich repeat kinase 2 (LRRK2) protein via up regulation of its target gene, 14/March/2014, 22.25,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation